peptidesgreyhouse

15% Discount For All Payment Made Via Bitcoin

IGF-1 LR3 peptide

What Is IGF-1 LR3 Peptide?

IGF-1 LR3 peptide, also known as Long R3 IGF-1 or Long-[Arg3]-IGF-I, is a modified analogue of insulin-like growth factor-1 (IGF-1) that has been investigated in biochemical and preclinical research.

IGF-1 is a naturally occurring peptide hormone involved in complex cellular signaling pathways. IGF-1 LR3 was developed as a structural analogue with modifications that distinguish it from native human IGF-1.

For laboratory researchers, IGF-1 LR3 is of interest because its modified structure provides an experimental model for investigating IGF-related molecular interactions, receptor signaling, protein binding, and peptide characterization.

IGF-1 LR3 should not be confused with native human IGF-1 or with mecasermin, a prescription recombinant human IGF-1 product. These materials have different identities, applications, regulatory contexts, and intended uses.

For a research product page, the appropriate positioning is therefore research use only, with emphasis on analytical documentation, molecular characterization, and controlled laboratory investigation.


IGF-1 LR3 Peptide at a Glance

IGF-1 LR3 peptide
IGF-1 LR3 peptide
Property Information
Common name IGF-1 LR3
Full name Long R3 Insulin-like Growth Factor-1
Alternative name Long-[Arg3]-IGF-I
Parent molecule Human IGF-1
Molecular class Modified peptide/protein analogue
Approximate length 83 amino acids
Common research presentation 1 mg
CAS number commonly associated with Long R3 IGF-1 143045-27-6
Research applications Biochemical and analytical research
Typical analytical documentation HPLC, mass spectrometry, COA
Intended product positioning Laboratory research use

The exact specifications of a particular product should always be verified against its current batch-specific documentation.


Understanding the Structure of IGF-1 LR3

One of the most important differences between native IGF-1 and IGF-1 LR3 is its molecular structure.

Native mature human IGF-1 consists of 70 amino acids. IGF-1 LR3 contains an additional N-terminal extension and incorporates an amino-acid substitution at position 3.

These structural modifications create the Long R3 form and make it a useful research analogue for studying IGF-related molecular behavior.

Key structural characteristics

IGF-1 LR3 is commonly described as having:

  • An 83-amino-acid peptide sequence
  • A 13-amino-acid N-terminal extension
  • An arginine substitution at position 3
  • Multiple cysteine residues involved in disulfide-bond formation
  • Structural similarity to the IGF-1 family

Because peptide structure directly influences molecular interactions, researchers can use analytical techniques to evaluate identity, purity, and molecular characteristics.


IGF-1 LR3 Molecular Weight

Molecular weight is an important analytical specification for IGF-1 LR3 peptide research.

Published references commonly place the molecular mass of Long R3 IGF-1 at approximately 9.1 kDa, although reported values can vary depending on whether theoretical, calculated, average, monoisotopic, or experimentally observed mass is being referenced.

For analytical work, researchers should distinguish between:

Theoretical molecular mass:
A value calculated from the amino-acid composition and molecular structure.

Observed molecular mass:
A value experimentally determined using an analytical technique such as mass spectrometry.

This distinction is particularly important when interpreting an analytical report or Certificate of Analysis.

Why molecular weight matters

Molecular-weight information can help researchers:

  1. Verify expected molecular identity.
  2. Interpret mass-spectrometry results.
  3. Compare experimental and theoretical mass.
  4. Investigate potential degradation products.
  5. Support peptide characterization.
  6. Assess whether analytical findings are consistent with the expected material.

For a commercial research page, molecular-weight information should be accompanied by appropriate qualification rather than presented as a substitute for batch-specific analytical testing.


IGF-1 LR3 Peptide HPLC Analysis

HPLC, or high-performance liquid chromatography, is one of the commonly used analytical techniques for evaluating peptide materials.

For an IGF-1 LR3 research product, an HPLC chromatogram can provide information about the chromatographic profile of the tested sample.

What HPLC can help evaluate

Depending on the analytical method, HPLC can be used to investigate:

  • Main peptide peak
  • Relative chromatographic purity
  • Potential related substances
  • Degradation products
  • Batch consistency
  • Sample profile

A research-grade product page should avoid treating a single HPLC percentage as proof of every aspect of product quality.

HPLC primarily provides chromatographic information. Other analytical techniques may be necessary to establish molecular identity and additional quality characteristics.

HPLC and research documentation

When presenting HPLC information online, useful documentation may include:

  • Test method
  • Analytical date
  • Sample identification
  • Chromatogram
  • Reported purity
  • Laboratory identification
  • Lot or batch number

This approach makes the product page more useful to researchers evaluating analytical documentation.


IGF-1 LR3 COA

A Certificate of Analysis (COA) provides batch-specific analytical information associated with a particular research material.

For IGF-1 LR3 peptide, a COA may include information such as:

  • Product name
  • Batch or lot number
  • Testing date
  • Appearance
  • Identification
  • HPLC purity
  • Molecular-mass testing
  • Analytical methods
  • Specification limits
  • Reported results

The availability and exact contents of a COA depend on the supplier and individual batch.

Why researchers review COAs

A COA can help researchers establish traceability between:

Product → Batch → Analytical testing → Reported result

This is particularly useful when multiple lots of a research peptide are being compared.

Researchers should ensure that any COA corresponds to the exact batch being evaluated rather than relying on a generic document from another production lot.


IGF-1 LR3 Purity

Purity is an important consideration when selecting a research peptide for analytical or biochemical studies.

However, the term purity should be interpreted according to the analytical method used.

For example, an HPLC purity result describes the chromatographic profile measured under a particular analytical method. It does not automatically establish:

  • Sterility
  • Endotoxin status
  • Biological activity
  • Long-term stability
  • Absence of every possible contaminant

For this reason, researchers should examine the complete available analytical documentation rather than relying on a single numerical purity claim.

Batch-specific verification

A strong research-product workflow includes:

  1. Identifying the exact batch.
  2. Reviewing the associated COA.
  3. Checking the reported analytical method.
  4. Reviewing HPLC results where available.
  5. Reviewing mass-spectrometry or identity data where available.
  6. Confirming storage and handling information supplied by the manufacturer.

IGF-1 LR3 Research Applications

IGF-1 LR3 has been investigated in experimental contexts related to the IGF signaling system.

Research involving IGF-related molecules can include areas such as:

Molecular signaling research

Researchers can investigate how IGF-related peptides interact with cellular signaling pathways.

Receptor studies

The IGF-1 receptor pathway is an important subject in molecular and cellular biology research.

Protein-binding studies

The structural modifications of Long R3 IGF-1 make it relevant to experimental investigations involving interactions between IGF-related molecules and binding proteins.

Peptide characterization

IGF-1 LR3 can also be examined using analytical techniques designed to characterize peptide identity, purity, molecular mass, and chromatographic behavior.

Comparative research

Researchers may compare native IGF-1 and modified analogues to investigate how structural changes influence molecular properties.

These applications describe research contexts, not approved medical uses.


IGF-1 LR3 vs. Native IGF-1

Although the names are similar, IGF-1 and IGF-1 LR3 are not identical.

Characteristic Native IGF-1 IGF-1 LR3
Basic molecule Human IGF-1 Modified IGF-1 analogue
Mature peptide length 70 amino acids Approximately 83 amino acids
N-terminal extension No Yes
Arg3 modification No Yes
Research interest IGF biology Modified IGF-related biology
Molecular characterization HPLC/MS and other methods HPLC/MS and other methods

The structural differences are central to understanding why IGF-1 LR3 is treated as a distinct research molecule.


IGF-1 LR3 vs. Mecasermin

Another important distinction is between IGF-1 LR3 and mecasermin.

Mecasermin is recombinant human IGF-1 used as a prescription medicine for specific medical indications. IGF-1 LR3 is a modified analogue used primarily in experimental and research contexts.

Therefore, an IGF-1 LR3 research material should not be marketed as mecasermin, represented as an approved medication, or described as interchangeable with prescription IGF-1.

This distinction is important for accurate scientific communication and responsible SEO content.


IGF-1 LR3 1mg Research Product

A 1mg IGF-1 LR3 presentation refers to the nominal quantity of peptide supplied.

The “1mg” designation does not describe a different molecular structure. It simply identifies the quantity of research material in the product presentation.

For researchers, the useful product information should extend beyond the quantity and include:

  • Product identity
  • Batch number
  • Purity information
  • HPLC documentation
  • Molecular-mass information
  • COA availability
  • Storage information
  • Research-use designation

A transparent product page can therefore combine product information with technical documentation to help qualified researchers evaluate the material.


Analytical Quality Considerations

Selecting a research peptide involves more than comparing product names.

Researchers may consider several analytical factors.

Identity

Is the material consistent with the expected IGF-1 LR3 molecule?

Purity

What does the reported analytical method indicate about the chromatographic profile?

Molecular mass

Does experimental mass correspond reasonably with the expected molecular mass?

Batch traceability

Can the analytical report be connected to a specific lot?

Documentation

Are relevant COA and analytical records available?

Storage information

Are appropriate storage conditions clearly documented by the supplier?

These factors can make an online research-product page substantially more useful than a page containing only a product name and quantity.


Storage and Handling Information

Research peptides are sensitive biomolecules, and their stability can depend on formulation, temperature, moisture, light exposure, container characteristics, and handling procedures.

Storage requirements should therefore follow the manufacturer’s batch-specific instructions and laboratory protocols.

Researchers should avoid assuming that every IGF-1 LR3 product has identical stability characteristics.

For laboratory documentation, it can be useful to record:

  • Product name
  • Lot number

    IGF-1 LR3 peptide
    IGF-1 LR3 peptide
  • Date received
  • Storage condition
  • Date opened or prepared
  • Relevant handling observations

This creates a traceable record for experimental work.


Research-Use-Only Statement

IGF-1 LR3 peptide is presented for research and laboratory use only. It is intended for qualified scientific investigation, analytical characterization, and controlled experimental workflows. It is not presented as a food, dietary supplement, cosmetic ingredient, or approved therapeutic product. It is not intended for human or veterinary administration. Researchers are responsible for following applicable institutional, regulatory, laboratory, storage, handling, and safety requirements.


Why Choose a Research-Focused IGF-1 LR3 Product Page?

A useful research-product page should provide more than commercial language.

Researchers benefit from access to:

  • Clear molecular identification
  • Product quantity
  • Batch information
  • HPLC documentation
  • COA information
  • Molecular-weight data
  • Research-use classification
  • Analytical terminology
  • Transparent product specifications

Combining these elements creates a page that can serve both search-engine discovery and technical research information needs.


Frequently Asked Questions

What is IGF-1 LR3 peptide?

IGF-1 LR3 is a modified analogue of human insulin-like growth factor-1. It is commonly studied in biochemical and preclinical research involving IGF-related molecular systems.

What does LR3 mean?

“LR3” refers to the Long R3 form of IGF-1. The molecule contains an N-terminal extension and an arginine substitution at position 3 compared with native IGF-1.

How many amino acids are in IGF-1 LR3?

IGF-1 LR3 is commonly described as an 83-amino-acid peptide analogue.

What is the molecular weight of IGF-1 LR3?

The molecular mass is commonly reported at approximately 9.1 kDa, although the precise reported value depends on the mass convention and analytical method.

What is IGF-1 LR3 1mg?

IGF-1 LR3 1mg refers to a research-product presentation containing a nominal 1 milligram quantity of IGF-1 LR3 material.

What is an IGF-1 LR3 COA?

A Certificate of Analysis is a batch-specific analytical document that can provide information about identity, purity, testing methods, and other reported specifications.

What is IGF-1 LR3 HPLC?

HPLC is a chromatographic analytical technique that can be used to evaluate the chromatographic purity profile and related characteristics of a peptide sample.

Is IGF-1 LR3 the same as IGF-1?

No. IGF-1 LR3 is a modified analogue of native IGF-1 with structural changes that distinguish it from the native molecule.

Is IGF-1 LR3 the same as mecasermin?

No. Mecasermin is recombinant human IGF-1 used as a prescription medicine for specific indications, whereas IGF-1 LR3 is a structurally modified research analogue.

What should researchers look for when evaluating IGF-1 LR3?

Researchers can review product identity, batch number, analytical purity, HPLC data, molecular-mass information, COA documentation, storage instructions, and traceability.


Conclusion

IGF-1 LR3 peptide is a modified IGF-1 analogue of interest in biochemical, molecular, and preclinical research. Its distinguishing structural features include the Long R3 configuration, an N-terminal extension, and an Arg3 substitution.

For research-product evaluation, analytical information is particularly important. HPLC, mass spectrometry, COA documentation, molecular-weight data, and batch traceability can help researchers understand the characteristics of a specific material.

For SEO and scientific accuracy, product content should clearly distinguish IGF-1 LR3 from native IGF-1 and prescription mecasermin, while maintaining research-use-only language and avoiding unsupported therapeutic claims.

Shopping Cart
0